Consolidated fourth quarter revenue of $48.8 million up 6.6% from prior year; full year revenue slightly above prior year
Service segment fourth quarter organic revenue grew 10% and gross margin expanded 500 basis points to 33.9%
Service segment surpassed $100 million in revenue and 30% gross margin milestones for the full year
Record full year operating income and operating cash flow of $11.1 million and $23.6 million, respectively
ROCHESTER, NY, May 18, 2021 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its fourth quarter and fiscal year ended March 27, 2021 (“fiscal 2021”). Results include the previously reported acquisitions of TTE Laboratories, Inc. (referred to as “pipettes.com”) effective February 21, 2020 and the acquisition of Bio Tek Services, Inc. (“Bio Tek”) effective December 16, 2020.